Virtu Financial’s PhenomeX Inc. Common Stock CELL Stock Holding History

Virtu Financial’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,968	Closed	-$24K	–	2257
2023 Q3	$24K	Buy	+23,968	New	+$18.4K	﹤0.01%	990
2022 Q4	–	Sell	-12,764	Closed	-$37K	–	2364
2022 Q3	$37K	Buy	+12,764	New	+$54.3K	﹤0.01%	1268
2021 Q4	–	Sell	-29,248	Closed	-$572K	–	2328
2021 Q3	$572K	Buy	29,248 +23,224	+386%	+$883K	0.05%	403
2021 Q2	$270K	Sell	6,024 -2,265	-27%	-$105K	0.03%	790
2021 Q1	$416K	Buy	+8,289	New	+$565K	0.03%	622

Virtu Financial's CELL Position: Q4 2023 in Review

Virtu Financial sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 23,968 shares — an estimated $24K sold.

Virtu Financial first reported a position in CELL in Q1 2021 and held it in 5 quarters. The position peaked at $572K in Q3 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Virtu Financial reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Virtu Financial sold 23,968 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $24K.
Virtu Financial first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Virtu Financial's PhenomeX Inc. Common Stock position peaked at $572K in Q3 2021.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.